drugset / Trial / NCT00485901

Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia

NCT00485901

Phase 3 Completed 50 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare intramuscular Olanzapine and intramuscular Haloperidol in changing of agitation in patients with schizophrenia

Timeline

Start
2004-07
Primary completion
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Haloperidol Other / unclassified Intramuscular
Subject Olanzapine Small molecule Intramuscular

Indications